Skip to main content
Top
Published in: Abdominal Radiology 6/2008

01-11-2008

Addison’s disease due to adrenal tuberculosis: MRI features

Authors: Xiao-Chun Zhang, Zhi-Gang Yang, Yuan Li, Peng-Qiu Min, Yin-Kun Guo, Yu-Ping Deng, Zhi-Hui Dong

Published in: Abdominal Radiology | Issue 6/2008

Login to get access

Abstract

Background

Findings of adrenal tuberculosis with MR scanning have never been reported in the literature. The aim of this study was to determine MR characteristics for tuberculous Addison’s disease, and evaluate the utility of MR imaging as a useful diagnosis tool of the entity.

Patients and methods

Eighteen patients with proven adrenal tuberculosis were included. All patients had conventional T1- and T2-weighted image. Among the 18 patients, contrast-enhanced T1WI had been done in 10. MR manifestations were retrospectively evaluated blindly for the location, contour, signal intensity, and enhancement patterns.

Results

All patients clinically exhibited hyperpigmentation and lethargy. Physical examination revealed weight loss, signs of dehydration, and hypotension. Biochemical investigation confirmed adrenal insufficiency. The adrenal glands were affected bilaterally in 16 patients (89%) and unilaterally in 2 patients (11%). Thirty-three glands were enlarged (97%), while one was atrophic (3%). Of the 33 enlarged glands, 20 (61%) were mass-like and 13 (39%) had preserved contours. The central region of the enlarged glands demonstrated T2 hypo- or iso-SI in 21 (62%) and T2 hyper-SI in 12 (38%). Among the 18 enlarged glands that had contrast MR, 15 (83%) had peripheral rim enhancement, 1 (6%) had homogeneous enhancement, and the last two (11%) had heterogeneous enhancement.

Conclusion

MR characteristics can reveal certain pathological changes of adrenal tuberculosis, and MR imaging could be recommended as the imaging modality for the diagnosis of the entity.
Literature
1.
go back to reference Yilmaz T, Sever A, Gur S, et al. (2002) CT findings of abdominal tuberculosis in 12 patients. Comput Med Imaging Graph 26:321–325PubMedCrossRef Yilmaz T, Sever A, Gur S, et al. (2002) CT findings of abdominal tuberculosis in 12 patients. Comput Med Imaging Graph 26:321–325PubMedCrossRef
2.
go back to reference Parmar H, Shah J, Patkar D, et al. (2004) Tuberculous arthritis of the appendicular skeleton: MR imaging appearances. Eur J Radiol 52:300–309PubMedCrossRef Parmar H, Shah J, Patkar D, et al. (2004) Tuberculous arthritis of the appendicular skeleton: MR imaging appearances. Eur J Radiol 52:300–309PubMedCrossRef
3.
4.
go back to reference Villabona CM, Sahun M, Ricart W, et al. (1993) Tuberculosis Addison’s disease: utility of CT in diagnosis and follow-up. Eur J Radiol 17(3):210–213PubMedCrossRef Villabona CM, Sahun M, Ricart W, et al. (1993) Tuberculosis Addison’s disease: utility of CT in diagnosis and follow-up. Eur J Radiol 17(3):210–213PubMedCrossRef
5.
6.
go back to reference Wilms GE, Baert AL, Kint EJ, et al. (1983) Computed tomographic findings in bilateral adrenal tuberculosis. Radiology 146:729–730PubMed Wilms GE, Baert AL, Kint EJ, et al. (1983) Computed tomographic findings in bilateral adrenal tuberculosis. Radiology 146:729–730PubMed
7.
go back to reference Guo YK, Yang ZG, Li Y, et al. (2006) Addison’s disease due to adrenal tuberculosis: contrast enhanced CT features and clinical duration correlation. Eur J Radiol 62:126–131PubMedCrossRef Guo YK, Yang ZG, Li Y, et al. (2006) Addison’s disease due to adrenal tuberculosis: contrast enhanced CT features and clinical duration correlation. Eur J Radiol 62:126–131PubMedCrossRef
8.
go back to reference Fan ZM, Zeng QY, Huo JW, et al. (1998) Macronodular multi-organs tuberculoma: CT and MR appearances. Gastroenterology 33:285–288CrossRef Fan ZM, Zeng QY, Huo JW, et al. (1998) Macronodular multi-organs tuberculoma: CT and MR appearances. Gastroenterology 33:285–288CrossRef
9.
go back to reference Murata Y, Yamada I, Sumiya Y, et al. (1996) Abdominal macronodular tuberculomas: MR findings. J Comput Assist Tomogr 20:643–646PubMedCrossRef Murata Y, Yamada I, Sumiya Y, et al. (1996) Abdominal macronodular tuberculomas: MR findings. J Comput Assist Tomogr 20:643–646PubMedCrossRef
10.
go back to reference Kawamori Y, Matsui O, Kitagawa K, et al. (1992) Macronodular: tuberculoma of the liver: CT and MR findings. Am J Roentgenol 158:311–313 Kawamori Y, Matsui O, Kitagawa K, et al. (1992) Macronodular: tuberculoma of the liver: CT and MR findings. Am J Roentgenol 158:311–313
11.
go back to reference She WC, Chen TY, Lee SK, et al. (1993) Disseminated tuberculomas in spinal cord and brain demonstrated by MRI with gadolinium-DTPA. Neuroradiology 35:213–215CrossRef She WC, Chen TY, Lee SK, et al. (1993) Disseminated tuberculomas in spinal cord and brain demonstrated by MRI with gadolinium-DTPA. Neuroradiology 35:213–215CrossRef
12.
go back to reference Yang ZG, Guo YK, Li Y, et al. (2006) Differentiation between tuberculosis and primary tumors in the adrenal gland: evaluation with contrast-enhanced CT. Eur J Radiol 16:2031–2036CrossRef Yang ZG, Guo YK, Li Y, et al. (2006) Differentiation between tuberculosis and primary tumors in the adrenal gland: evaluation with contrast-enhanced CT. Eur J Radiol 16:2031–2036CrossRef
13.
go back to reference Zar T, Khan F, Petit W Jr, et al. (2004) Primary adrenal lymphoma presenting as adrenal insufficiency: a case report and review of literature. Conn Med 68:7–10PubMed Zar T, Khan F, Petit W Jr, et al. (2004) Primary adrenal lymphoma presenting as adrenal insufficiency: a case report and review of literature. Conn Med 68:7–10PubMed
14.
go back to reference Prokesch RW, Schima W, Berlakovich G, et al. (2001) Adrenal hemorrhage after orthotopic liver transplantation: MR appearance. Eur J Radiol 11:2481–2487 Prokesch RW, Schima W, Berlakovich G, et al. (2001) Adrenal hemorrhage after orthotopic liver transplantation: MR appearance. Eur J Radiol 11:2481–2487
15.
go back to reference Gomori JM, Grossmann RI, Yu-Ip C, et al. (1987) NMR relaxation times of blood: dependence on field strength, oxidation state, and ceel integrity. J Comput Assist Tomogr 11:684–690PubMedCrossRef Gomori JM, Grossmann RI, Yu-Ip C, et al. (1987) NMR relaxation times of blood: dependence on field strength, oxidation state, and ceel integrity. J Comput Assist Tomogr 11:684–690PubMedCrossRef
16.
go back to reference Lio S, Cibin M, Marcello R, et al. (2000) Adrenal bilateral incidentaloma by reactivated histoplasmosis. J Endocrinol Invest 23:476–479PubMed Lio S, Cibin M, Marcello R, et al. (2000) Adrenal bilateral incidentaloma by reactivated histoplasmosis. J Endocrinol Invest 23:476–479PubMed
17.
go back to reference Kumar N, Singh S, Govil S (2003) Adrenal histoplasmosis: clinical presentation and imaging features in nine cases. Abdom Imaging 28:703–708PubMedCrossRef Kumar N, Singh S, Govil S (2003) Adrenal histoplasmosis: clinical presentation and imaging features in nine cases. Abdom Imaging 28:703–708PubMedCrossRef
Metadata
Title
Addison’s disease due to adrenal tuberculosis: MRI features
Authors
Xiao-Chun Zhang
Zhi-Gang Yang
Yuan Li
Peng-Qiu Min
Yin-Kun Guo
Yu-Ping Deng
Zhi-Hui Dong
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 6/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9352-8

Other articles of this Issue 6/2008

Abdominal Radiology 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine